Leigh Boulware to Adrenergic beta-Antagonists
This is a "connection" page, showing publications Leigh Boulware has written about Adrenergic beta-Antagonists.
Connection Strength
0.064
-
Shafi T, Sozio SM, Luly J, Bandeen-Roche KJ, St Peter WL, Ephraim PL, McDermott A, Herzog CA, Crews DC, Scialla JJ, Tangri N, Miskulin DC, Michels WM, Jaar BG, Zager PG, Meyer KB, Wu AW, Boulware LE. Antihypertensive medications and risk of death and hospitalizations in US hemodialysis patients: Evidence from a cohort study to inform hypertension treatment practices. Medicine (Baltimore). 2017 Feb; 96(5):e5924.
Score: 0.035
-
Shafi T, Sozio SM, Bandeen-Roche KJ, Ephraim PL, Luly JR, St Peter WL, McDermott A, Scialla JJ, Crews DC, Tangri N, Miskulin DC, Michels WM, Jaar BG, Herzog CA, Zager PG, Meyer KB, Wu AW, Boulware LE. Predialysis systolic BP variability and outcomes in hemodialysis patients. J Am Soc Nephrol. 2014 Apr; 25(4):799-809.
Score: 0.028